RE:RE:RE:RE:Just tried THC product AMAI do agree on a strictly investor perspective that they need to do more. That being said, the company seems to be moving along fine in terms of building a business. They are only 1 in 6 companies with the 3 licenses they have, which begs to question why some companies without a license are way ahead of them in market cap. Obviously it's because investors think that pumping a stock is more important than fundamentals. Sure you can ignore the fact that they obtained Clone Shipper, yet claim it's a game changer when Aurora copies it, but eventually the fundamentals start to add up and become impossible to ignore..
BTW even if they aren't selling certain strains ATM we know they still have the strains secured in their inventory and will be able to produce more as they develop their business. It also sounds like they keep selling out of their product, which I don't see how you can interpret as bad for any company to sell out their product faster than they can produce it. This provides security as they build knowing that everything they produce they will likely sell. As for patients getting angry with them and moving on, it reminds me when my sources would run out. I'd find other sources, but if I liked what they sold and especially if I liked the cost, then I'd go back and check to see when they restocked. Potheads aren't known for holding a grudge unless you stiff them with bad quality weed or not provide as much as you said you gave them. So as soon as THC can keep up with demand, patients will come back
Nikopain wrote: oh and as i said in my review, i agree with you that the low price is VERY VERY VERY attractive to patients becuase this sh***t is reallly expensive compared to what we were used to pay on the black market, but most people want to purchase legally so we are trying to get good quality and good price which THC does offer.
But the caveat is that they are experiencing some problems with logistics (which can be easily solved honestly) but the biggest concern is that if they have an influx of patients with small production capabilities, they will piss of patients once their products are unavailable,so far that hasnt happen.
What they really need to do is inform shareholders on theri production capacity and expansion plans. They say they will be ready for REC, but we have yet to see plans. If they do and it makes sense, ill be back